Companies: 10,795·Total market cap: $144.5T
Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDLNASDAQHealthcare● Active
$1.08
$-0.03(-2.70%)
Market Cap$120821760
P/E Ratio—
52W High$1.71
52W Low$0.88
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Cardiol Therapeutics Inc. (CRDL) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001702123 · CRDL · NASDAQ · as of Jun 10, 2026

Filing snapshot

167
Total Filings
6-K
Latest Form
2026-05-26
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001702123 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2024-04-01
Fiscal Year End
Apr 1, 2024
Accession No.
0001104659-24-041952
Primary Document
crdl-20231231x20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001702123 · Accession 0001104659-24-041952

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-05-26
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-11
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-28
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-14
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-10
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-01
View
40-F40-F
40-F
2026-03-31
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-25
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-10
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-02
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-01-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-26
View
Showing 1–15 of 167 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001702123  |  Exchange: NASDAQ · Healthcare

Cardiol Therapeutics Inc. (NASDAQ: CRDL) has submitted 167 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001702123, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Cardiol Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Cardiol Therapeutics Inc. 10-K was filed on 2024-04-01 for fiscal year ending 2024. Historical CRDL 10-K annual reports are available from 2017 through 2024.

Investors researching Cardiol Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
ASRT SEC Filings →CNTB SEC Filings →IFRX SEC Filings →HYPR SEC Filings →MBOT SEC Filings →KLRS SEC Filings →VANI SEC Filings →IMA SEC Filings →
→ CRDL Financials→ CRDL Earnings→ CRDL Insider Trades

Frequently Asked Questions

CRDL SEC Filings · 8 questions

Cardiol Therapeutics Inc. (CRDL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 167 filings and access original documents at no cost. Cardiol Therapeutics Inc.'s CIK is 0001702123.

CRDL SEC filingsCardiol Therapeutics Inc. SEC documentsfind CRDL 10-K